FDA Withdraws Approval For Drug Touted By Trump

The Washington Post reports:

The Food and Drug Administration has withdrawn its emergency use authorization for hydroxychloroquine to treat coronavirus patients. President Trump had repeatedly promoted the antimalarial drug as a way to prevent or treat covid-19.

The agency said Monday in a statement that “it is no longer reasonable to believe” the drug may be effective against covid-19 or that its benefits outweigh “known and potential risks.”

The move comes after months of questions and criticisms about the FDA’s authorization of the product, which can cause potential heart-rhythm problems.